Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

Powershares Dynamic Biotechnology & Genome Portfolio

+ Add to Watchlist

PBE:US

54.8200 USD 0.7200 1.30%

As of 20:04:05 ET on 02/27/2015.

Snapshot for Powershares Dynamic Biotechnology & Genome Portfolio (PBE)

Open: 55.8600 High - Low: 55.8600 - 54.7401 Primary Exchange: NYSE Arca
Volume: 48,413 52-Week Range: 36.8800 - 55.8600 Beta vs DZOTR: 1.0026

ETF Chart for PBE

No chart data available.
  • PBE:US 54.8200
  • 1D
  • 1M
  • 1Y
55.5400
Interactive PBE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for PBE

PowerShares Dynamic Biotechnology & Genome Portfolio is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of the Dynamic Biotechnology & Genome Intellidex Index, a fundamentally-weighted index. Securities shown to possess the greatest capital appreciation potential are selected by the Index.

Inception Date: 2005-06-23 Telephone: 1-800-983-0903
Managers: PETER HUBBARD / MICHAEL JEANETTE
Web Site: www.powershares.com

Fundamentals for PBE

NAV (on 2015-02-27) 54.8025
Assets (M) (on 2015-02-27) 526.1038
Shares out (M) 9.60
Market Cap (M) 526.27
% Premium 0.03
Average 52-Week % Premium 0.0017
Fund Leveraged N

Dividends for PBE

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-09-19) 0.0429
Dividend Yield (ttm) 0.51%

Performance for PBE

1-Month +3.49% 1-Year +22.17%
3-Month +8.00% 3-Year +35.50%
Year To Date +9.20% 5-Year +25.47%
Expense Ratio 0.63

Top Fund Holdings for PBE

Filing Date: 02/27/2015
Name Position Value % of Total
Biogen Idec Inc 78,995 32,355,562 6.149%
BioMarin Pharmaceutical Inc 270,932 29,008,689 5.513%
Gilead Sciences Inc 242,305 25,085,837 4.768%
Illumina Inc 127,338 24,889,485 4.730%
Sigma-Aldrich Corp 177,953 24,568,191 4.669%
Regeneron Pharmaceuticals Inc 58,414 24,174,050 4.594%
Amgen Inc 147,047 23,192,253 4.408%
Alexion Pharmaceuticals Inc 124,716 22,495,025 4.275%
Insys Therapeutics Inc 342,343 20,561,121 3.908%
Pharmacyclics Inc 95,115 20,538,182 3.903%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil